Cardiovascular failure in mouse embryos deficient in VEGF receptor-3

Science

Volumn 282, Issue 5390, 1998, Pages 946-949

  Dumont, Daniel J ^a,d   Jussila, Lotta ^b   Taipale, Jussi ^b   Lymboussaki, Athina ^b   Mustonen, Tuija ^b   Pajusola, Katri ^b   Breitman, Martin ^c   Alitalo, Kari ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF HELSINKI   (Finland)

^c MOUNT SINAI HOSPITAL   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RESPONSE; EMBRYO; ENZYME ACTIVITY; EXON; GENE EXPRESSION; GENETIC CODE; HEART FAILURE; LYMPH VESSEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; ANTIGENS, CD31; BLOOD VESSELS; CARDIOVASCULAR SYSTEM; EMBRYO; EMBRYONIC AND FETAL DEVELOPMENT; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GENE TARGETING; HEMATOPOIESIS; HETEROZYGOTE; HOMOZYGOTE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIGANDS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 0032582502     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.282.5390.946     Document Type: Article

References (38)

1. P. Carmeliet et al., Nature 380, 435 (1996); N. Ferrara et al., ibid., p. 439.
2. P. Carmeliet et al., Nature 380, 435 (1996); N. Ferrara et al., ibid., p. 439.
3. F. Shalaby et al., ibid. 376, 62 (1995).
4. G. H. Fong, J. Rossant, M. Gertsenstein, M. L. Breitman, ibid., p. 66.
5. N. Ferrara and T. Davis-Smyth, Endocr. Rev. 18, 4 (1997); E. I. Korpelainen and K. Alitalo, Curr. Opin. Cell Biol. 10, 159 (1998).
6. N. Ferrara and T. Davis-Smyth, Endocr. Rev. 18, 4 (1997); E. I. Korpelainen and K. Alitalo, Curr. Opin. Cell Biol. 10, 159 (1998).
7. J. E. Park et al., J. Biol. Chem. 269, 25646 (1994); A. Sawano et al., Cell Growth Differ. 7, 213 (1996); B. Olofsson et al., Proc. Natl. Acad. Sci. U.S.A. 95, 11709 (1998).
8. J. E. Park et al., J. Biol. Chem. 269, 25646 (1994); A. Sawano et al., Cell Growth Differ. 7, 213 (1996); B. Olofsson et al., Proc. Natl. Acad. Sci. U.S.A. 95, 11709 (1998).
9. J. E. Park et al., J. Biol. Chem. 269, 25646 (1994); A. Sawano et al., Cell Growth Differ. 7, 213 (1996); B. Olofsson et al., Proc. Natl. Acad. Sci. U.S.A. 95, 11709 (1998).
10. M. Jeltsch et al., Science 276, 1423 (1997); S. J. Oh et al., Dev. Biol. 188, 96 (1997).
11. M. Jeltsch et al., Science 276, 1423 (1997); S. J. Oh et al., Dev. Biol. 188, 96 (1997).
12. V. Joukov et al., EMBO J. 15, 290 (1996); J. Lee et al., Proc. Natl. Acad. Sci. U.S.A. 93, 1988 (1996).
13. V. Joukov et al., EMBO J. 15, 290 (1996); J. Lee et al., Proc. Natl. Acad. Sci. U.S.A. 93, 1988 (1996).
14. M. G. Achen et al., Proc. Natl. Acad. Sci. U.S.A. 95, 548 (1998); A. Eichmann et al., Development 125, 743 (1998).
15. M. G. Achen et al., Proc. Natl. Acad. Sci. U.S.A. 95, 548 (1998); A. Eichmann et al., Development 125, 743 (1998).
16. A. Kaipainen et al., Proc. Natl. Acad Sci. U.S.A. 92, 3566 (1995); E. Kukk et al., Development 122, 3829 (1996).
17. A. Kaipainen et al., Proc. Natl. Acad Sci. U.S.A. 92, 3566 (1995); E. Kukk et al., Development 122, 3829 (1996).
18. We generated a null VEGFR-3 allele by introducing a LacZ cassette into the VEGFR-3 locus (11). The 3-kb Kpn I-Not I and Bam HI-Kpn I fragments from 129SV mouse genomic DNA library (λFIX II; Stratagene) were used as the arms of the targeting vector (Fig. 1). The gene-targeting event was confirmed by Southern (DNA) blot analysis (Fig. 1) (D. J. Dumont et al., data not shown), and two independent embryonic stem cell lines were used to make heterozygous mice through blastocyst injection. Wild-type, heterozygous, and homozygous embryos and mice were identified by Southern blot analysis of yolk sac and tail DNA, respectively.
19. L. Jussila, J. Taipale, K. Alitalo, unpublished data.
20. M. C. Puri et al., EMBO J. 14, 5884 (1995).
21. F. R. Sabin, Anat. Rec. 6, 335 (1912).
22. Embryos were stained for β-Gal (12), photographed, and subsequently dehydrated and embedded in paraffin. Seven-micrometer sections were stained immunohistochemically for PECAM-1 (Pharmingen, San Diego, CA) with TSA Kit (NEN, Boston, MA). Mouse VEGFR-3 [base pairs (bp) 22 to 214; GenBank L07296] and VEGF-C (bp 499 to 656; GenBank U73620) cDNA probes were used for in situ hybridization (9).
23. For a review, see W. Risau, Nature 386, 671 (1997).
24. A. Vecchi et al., Eur. J. Cell Biol. 63, 247 (1994).
25. The presence of VEGFR-3 mRNA in endothelial cells of the dorsal aorta and the yolk sac was confirmed by in situ hybridization (A. Lymboussaki and K. Alitalo, data not shown).
26. J. Rossant, Circ. Res. 78, 349 (1996).
27. S. Hiratsuka et al., Proc. Natl. Acad. Sci. U.S.A. 95, 9349 (1998).
28. J. E. Visvader, Y. Fujiwara, S. H. Orkin, Genes Dev. 12, 473 (1998).
29. L. C. Wang et al., EMBO J. 16, 4374 (1997).
30. P. Carmeliet et al., Nature 383, 73 (1996).
31. L. Wojnowski et al., Nature Genet. 16, 293 (1997).
32. T. N. Sato et al., Nature 376, 70 (1995).
33. H. U. Wang, F.-F. Chen, D. J. Anderson, Cell 93, 741 (1998).
34. M. Oshima, H. Oshima, M. M. Taketo, Dev. Biol. 179, 297 (1996).
35. C. Suri et al., Cell 87, 1161 (1997).
36. P. Lindahl et al., Science 277, 242 (1997).
37. C. T. K. Kuo et al., Genes Dev. 11, 2996 (1997).
38. We thank A. Kaipainen for helpful discussions, E. Koivunen for expert help with the mice, and M. Helanterä, P. Ylikantola, and T. Tainola for technical assistance. Supported by research grants from the Medical Research Council (Canada) and AMGEN (to D.J.D.) and by the Finnish Cancer Organizations, the Finnish Academy, the Sigrid Juselius Foundation, the Finnish State Technology Development Centre, and the European Union Biomed Program.